Daniel is the Director General responsible for advancing the Government of Canada’s pharmaceuticals policy agenda, including national pharmacare and the National Strategy for Drugs for Rare Diseases.
Day 1 Oct 6, 2026
Day 2 Oct 7, 2026
Daniel is the Director General responsible for advancing the Government of Canada’s pharmaceuticals policy agenda, including national pharmacare and the National Strategy for Drugs for Rare Diseases.
Day 1 Oct 6, 2026
Day 2 Oct 7, 2026